statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

enGene Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

enGene Holdings Inc. (Nasdaq: ENGN, enGene or the Company), a clinical-stage genetic medicines company whose non-viral, intravesical lead product candidate, EG-70, is in a pivotal study for...

enGene Announces Appointment of Ron Cooper as Chief Executive Officer

Why Are EnGene Holdings Shares Trading Lower Friday?

EnGene Holdings Inc. shares are trading lower Friday after the company, reported its financial results for the second quarter.
read more...

enGene Reports Second Quarter 2024 Financial Results and Provides a Business Update

enGene to Present at the Jefferies Global Healthcare Conference

enGene Holdings Inc. (Nasdaq: ENGN or enGene or the Company), a clinical-stage genetic medicines company whose non-viral lead program EG-70 is in a pivotal study for BCG-unresponsive non-muscle...

enGene Announces the Election of Paul Hastings and Wouter Joustra to its Board of Directors

enGene to Present Details of its Pivotal Phase 1/2 LEGEND Study of EG-70 in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer with Carcinoma in situ at the American Urology Association 2024 Annual Meeting

enGene to Present Details of its Pivotal Phase 1/2 LEGEND Study of EG-70 in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer with Carcinoma in situ at the American Urology Association 2024 Annual...

/C O R R E C T I O N -- enGene Inc./

/C O R R E C T I O N -- enGene Inc./ /C O R R E C T I O N -- enGene Inc./ PR Newswire BOSTON and MONTREAL, April 9, 2024 In the news release, engender Announces Hiring of Dr. Raja Ruth as Senior Vice...

engender Announces Hiring of Dr. Raja Ruth as Senior Vice President, Urologic Oncology and Clinical Development

engender Announces Hiring of Dr. Raja Ruth as Senior Vice President, Urologic Oncology and Clinical Development engender Announces Hiring of Dr. Raja Ruth as Senior Vice President, Urologic Oncology...

enGene Reports First Quarter 2024 Financial Results and Recent Corporate Progress

enGene Reports First Quarter 2024 Financial Results and Recent Corporate Progress enGene Reports First Quarter 2024 Financial Results and Recent Corporate Progress PR Newswire BOSTON and MONTREAL...

enGene Holdings, Inc. is a clinical-stage biotechnology company, which engages in developing gene therapies. It is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs. The company was founded by Anthony T. Cheung on April 24, 2023 and is headquartered in Saint-Laurent, Canada.

Volume	101,260.00
52-Wk High	$47.17
52-Wk Low	$6.69

ENGN enGene Holdings Inc

About

Feed

News

Sentiment

Fundamentals